Volumetric brain reductions in adult patients with phenylketonuria and their relationship with blood phenylalanine levels
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Volumetric brain reductions in adult patients with phenylketonuria and their relationship with blood phenylalanine levels ; volume:16 ; number:1 ; day:21 ; month:6 ; year:2024 ; pages:1-10 ; date:12.2024
Journal of neurodevelopmental disorders ; 16, Heft 1 (21.6.2024), 1-10, 12.2024
- Creator
-
Pardo, Jèssica
Capdevila-Lacasa, Clara
Segura, Bàrbara
Pané, Adriana
Montserrat, Cristina
Talló Forga-Visa, Maria de
Moreno, Pedro J.
Garrabou, Glòria
Grau-Junyent, Josep M.
Junqué, Carme
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s11689-024-09553-w
- URN
-
urn:nbn:de:101:1-2409122114263.180539227759
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pardo, Jèssica
- Capdevila-Lacasa, Clara
- Segura, Bàrbara
- Pané, Adriana
- Montserrat, Cristina
- Talló Forga-Visa, Maria de
- Moreno, Pedro J.
- Garrabou, Glòria
- Grau-Junyent, Josep M.
- Junqué, Carme
- SpringerLink (Online service)
Other Objects (12)
Improving phenylalanine and micronutrients status of children with phenylketonuria: a pilot randomized study
Phenylalanine free infant formula in the dietary management of phenylketonuria
A culture model for the assessment of phenylalanine neurotoxicity in phenylketonuria
A culture model for the assessment of phenylalanine neurotoxicity in phenylketonuria
Carnitine Status in Early-Treated Children, Adolescents and Young Adults with Phenylketonuria on Low Phenylalanine Diets
Sjogren-Larsson syndrome brain volumetric reductions demonstrated with an automated software
The impact of phenylalanine fluctuations on neurocognitive function in children and adolescents with early and continuously treated phenylketonuria
Carbohydrate status in patients with phenylketonuria
High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double-blind, placebo-controlled, crossover trial
The spectrum of phenylalanine hydroxylase variants and genotype–phenotype correlation in phenylketonuria patients in Gansu, China
Phenylketonuria Screening with a Fluorometric Microplate Assay
Aspartame and Phenylketonuria: an analysis of the daily phenylalanine intake of aspartame-containing drugs marketed in France
Improving phenylalanine and micronutrients status of children with phenylketonuria: a pilot randomized study
Phenylalanine free infant formula in the dietary management of phenylketonuria
A culture model for the assessment of phenylalanine neurotoxicity in phenylketonuria
A culture model for the assessment of phenylalanine neurotoxicity in phenylketonuria
Carnitine Status in Early-Treated Children, Adolescents and Young Adults with Phenylketonuria on Low Phenylalanine Diets
Sjogren-Larsson syndrome brain volumetric reductions demonstrated with an automated software
The impact of phenylalanine fluctuations on neurocognitive function in children and adolescents with early and continuously treated phenylketonuria
Carbohydrate status in patients with phenylketonuria
High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double-blind, placebo-controlled, crossover trial
The spectrum of phenylalanine hydroxylase variants and genotype–phenotype correlation in phenylketonuria patients in Gansu, China
Phenylketonuria Screening with a Fluorometric Microplate Assay
Aspartame and Phenylketonuria: an analysis of the daily phenylalanine intake of aspartame-containing drugs marketed in France
Improving phenylalanine and micronutrients status of children with phenylketonuria: a pilot randomized study
Phenylalanine free infant formula in the dietary management of phenylketonuria
A culture model for the assessment of phenylalanine neurotoxicity in phenylketonuria
A culture model for the assessment of phenylalanine neurotoxicity in phenylketonuria
Carnitine Status in Early-Treated Children, Adolescents and Young Adults with Phenylketonuria on Low Phenylalanine Diets
Sjogren-Larsson syndrome brain volumetric reductions demonstrated with an automated software
The impact of phenylalanine fluctuations on neurocognitive function in children and adolescents with early and continuously treated phenylketonuria
Carbohydrate status in patients with phenylketonuria
High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double-blind, placebo-controlled, crossover trial
The spectrum of phenylalanine hydroxylase variants and genotype–phenotype correlation in phenylketonuria patients in Gansu, China
Phenylketonuria Screening with a Fluorometric Microplate Assay